Tirzepatide 50mg

Description

Tirzepatide 50mg Research Product Overview

Tirzepatide 50mg is available from Polaris Peptide for qualified laboratory research, analytical workflows, and controlled in-vitro study environments. This product page is written for researchers who want clear product information before they buy Tirzepatide 50mg online for research use. The listing keeps the focus on product identity, strength, handling expectations, quality documentation, and the internal resources needed to review the item before placing an order.

Tirzepatide 50mg Product Details

Tirzepatide 50mg is categorized under GLP-1 & GIP Analogues and is listed as SKU PLT50. The selected product strength is 50mg. Buy Tirzepatide 50 mg – Dual GLP-1/GIP-Receptor Agonist Peptide, High Purity Lyophilized 50 mg vial, >99 % purity (HPLC-MS) and vacuum-sealed. Store -20 degrees C dry; 2-8 degrees C reconstituted; complete work within 28 days. For laboratory research only. Not intended for human or veterinary applications. Polaris Peptide presents this information so researchers can compare the product name, size, category, and available laboratory data in one place before adding the item to a research supply order.

Tirzepatide 50mg COA, Lab Testing, and Quality Information

Researchers reviewing Tirzepatide 50mg should check the COA/Lab Testing information, batch notes, purity details, mass data, and any chemical information shown below. Where available, this page includes chemical identifiers, molecular formula, molecular weight, latest lab results, and previous lab-result summaries. These details help make the product page more useful for product comparison, documentation review, and purchase decisions while keeping the page aligned with research-use-only language.

Buy Tirzepatide 50mg from Polaris Peptide

Buy Tirzepatide 50 mg — Dual GLP‑1/GIP‑Receptor Agonist Peptide, High Purity
Lyophilized 50 mg vial, >99 % purity (HPLC‑MS) and vacuum‑sealed. Store −20 °C dry; 2–8 °C reconstituted; complete work within 28 days. For laboratory research only. Not intended for human or veterinary applications. ‘Tirzepatide 50mg research peptide vial’. This item is not intended for human or veterinary use, clinical use, diagnostic use, therapeutic use, or consumer use.

Latest Lab Results

• Janoshik – March 10, 2026: Avg. Mass: 58.67mg; Avg. Purity: 99.883%; Batch: POL-T50-6

Previous Lab Results

• TrustPointe Analytics – September 30, 2025: Avg. Mass: 58.520mg; Avg. Purity: 99.418%; Batch: POL-T50-4
• TrustPointe Analytics – April 25, 2025: Bacterial Endotoxin: <5.00 EU/mL; Batch: POLT50-3
• TrustPointe Analytics – April 24, 2025: Avg. Mass: 50.4375mg; Avg. Purity: 99.858%; Batch: POL-T50-3
• TrustPointe Analytics – January 13, 2025: Avg. Mass: 56.370mg; Avg. Purity: 99.843%; Batch: POL-T50-2
• Chromate – October 4, 2024: Mass: 53.75mg; Purity: 99.763%; Batch: POL-T50-1

Helpful Polaris Peptide resources: View our research peptide shop, COA/Lab Testing, Research Use Disclaimer, Shipping & Payment, and FAQ.